Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer-Reference-Cited by-同舟云学术

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

Published:2010-04-19 Issue:6 Volume:3 Page:696-706
ISSN:1940-6207
Container-title:Cancer Prevention Research
language:en
Short-container-title:Cancer Prev Res

Author:

Vogel Victor G.,Costantino Joseph P.,Wickerham D. Lawrence,Cronin Walter M.,Cecchini Reena S.,Atkins James N.,Bevers Therese B.,Fehrenbacher Louis,Pajon Eduardo R.,Wade James L.,Robidoux André,Margolese Richard G.,James Joan,Runowicz Carolyn D.,Ganz Patricia A.,Reis Steven E.,McCaskill-Stevens Worta,Ford Leslie G.,Jordan V. Craig,Wolmark Norman

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 548 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone therapy in women with benign breast disease – What little is known and suggestions for clinical implementation;Maturitas;2024-07

2. Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial;Contemporary Clinical Trials;2024-07

3. Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer;Journal of Clinical Medicine;2024-06-20

4. Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review;Open Biology;2024-06

5. Effects of vitamin D supplementation on a deep learning–based mammographic evaluation in SWOG S0812;JNCI Cancer Spectrum;2024-05-30